1.
Acta Pharmaceutica Sinica B
;
(6): 4032-4044, 2021.
Artículo
en Inglés
| WPRIM
| ID: wpr-922458
RESUMEN
Insurmountable blood‒brain barrier (BBB) and complex pathological features are the key factors affecting the treatment of Alzheimer's disease (AD). Poor accumulation of drugs in lesion sites and undesired effectiveness of simply reducing A